MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses

• Jong W. Yu,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Sandy Hoffman,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Allison M. Beal,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Angela Dykon,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Michael A. Ringenberg,

  Affiliation Department of Safety Assessment, GlaxoSmithKline, King of Prussia, United States of America

  ⨯
• Anna C. Hughes,

  Affiliation Department of Safety Assessment, GlaxoSmithKline, King of Prussia, United States of America

  ⨯
• Lauren Dare,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Amber D. Anderson,

  Affiliation Quantitative Sciences, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Joshua Finger,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Viera Kasparcova,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• David Rickard,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Scott B. Berger,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Joshi Ramanjulu,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• John G. Emery,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• Peter J. Gough,

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• John Bertin ,

  * E-mail: john.j.bertin@gsk.com

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
•  [ ... ],
• Kevin P. Foley

  Affiliation Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, United States of America

  ⨯
• [ view all ]
• [ view less ]